Impact

The PerPrev-CID project will drive significant advancements in personalised prevention for RA and IBD, delivering scientific, technological, economic, and societal benefits.

• Scientific impact
  Currently, there is a lack of diagnostic tools, biomarkers, and early interventions for personalised risk prediction and prevention in RA and IBD. PerPrev-CID will enhance our understanding of early disease mechanisms and identify biomarkers and targets for prevention. The project will develop clinical decision support tools for individualised risk stratification, predicting the risk of disease onset and relapse in RA and IBD. These tools will be validated and accessible to the scientific and clinical community, serving as a blueprint for future CID projects by integrating omics, dietary, and lifestyle data into clinical applications.
• Technological impact
  The project will develop data-driven risk prediction tools and personalized preventive interventions for CIDs by integrating molecular data with eHealth and electronic patient reported outcome measure (ePROM) parameters. It will establish guidelines for continuous health monitoring systems, focusing on secure, privacy-preserving data exchange and using explainable AI (XAI) for predictive analysis. This will enhance trust in digitally-supported health interventions and advance the use of technology in this field of medicine.
• Economic impact
  The development of innovative medical devices and digital health applications will have a significant economic impact by promoting cost-effective, low-threshold preventive interventions for individuals at risk of RA and IBD. This will help reduce disease burden through better risk management, earlier diagnosis, and prevention, ultimately saving costs by preventing disease progression and reducing clinical management expenses.
• Societal impact
  The project will have a positive societal impact by raising awareness about innovative treatments, and reducing disease burden and secondary effects of RA and IBD. By developing digital eHealth tools and personalised prevention schemes, it will improve health literacy, enabling people with chronic conditions to better self-assess their risks and take an active role in managing their health decisions, leading to empowerment, better health outcomes and more efficient healthcare interactions.